Transcript of Copy of CAT devant une péritonite. rappel anatomique. Rappel anatomo-physiologique physiopathologie dc positif dc etiologies. CAT devant une lvation de la cratinine plasmatique – PowerPoint PPT . CAT DEVANT UNE ASCITE – CAT DEVANT UNE ASCITE Dr SAOULA Plan DEFINIR . Download File 4-CAT devant une ascite [Enregistrement automatique].pptx. You have requested Filesize ( KB).

Author: Dailkree Vukasa
Country: Liberia
Language: English (Spanish)
Genre: Love
Published (Last): 20 October 2007
Pages: 87
PDF File Size: 4.96 Mb
ePub File Size: 6.84 Mb
ISBN: 356-7-26098-273-4
Downloads: 71301
Price: Free* [*Free Regsitration Required]
Uploader: Yolkree

Click here to see the Library ]. Quel que soit le tableau symptomatique, la prise en charge varie selon que le diagnostic de CP est fait ou non. Il comporte au minimum un examen clinique minutieux et un scanner thoraco-abdomino-pelvien.

Le diagnostic de CP est souvent difficile. Le diagnostic de certitude repose sur la cytologie ou l’histologie. La CP est parfois responsable de la formation d’une devanf. Peritoneal carcinomatosis from devwnt malignancies. A survey of practice in management of malignant ascites. Management of symptomatic malignant ascites with diuretics: Control of malignant ascites with spironolactone. Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics.

A comparison of peritoneovenous shunting and nonoperative management.

Sonographically guided paracentesis for palliation of symptomatic malignant ascites. Indwelling catheters for the management of malignant ascites. Sonographically guided peritoneal catheter placement in the palliation of malignant ascites in end-stage malignancies.

Kne treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt. Peritoneovenous shunts in malignant ascites. Peritoneovenous shunts in the management of malignant ascites.

Le scanner est l’examen de choix chez un patient en occlusion dans un contexte de CP [ 35 Click here to see the Library et 39 Click here to see the Library ]. Management of bowel obstruction in patients with abdominal cancer.

The pathophysiology and management of malignant intestinal obstruction. Oxford textbook of palliative medicine. Oxford University Press Un avis chirurgical est donc indispensable. C’est rarement le cas dans un contexte de CP [ 41 Click here to see the Library46 Click here to see the Library et 48 Click here to devqnt the Library ].

asciite

CAT devant une lvation de la cratinine plasmatique – PowerPoint PPT Presentation

Le plus souvent le tableau clinique est progressif et laisse le temps d’un bilan. Intestinal obstruction in patients with widespread intraabdominal malignancy. Nutrition et hydratation en fin de vie. L’occlusion, surtout si elle est basse, ne contre indique azcite l’alimentation orale. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy.

  JENNIFER HORSMAN CRIMSON RAPTURE PDF

Standards, options et recommandations: Survival prediction in terminal cancer patients: Click here to see the Library ]: Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Medical management of bowel obstruction. Medical management of intestinal obstruction in patients with advanced malignant disease.

A clinical and pathological study. Ascitw agents in gastrointestinal obstruction. Nausea and vomiting in advanced cancer. Symptom control in terminally ill patients with malignant bowel obstruction. Palliation of malignant intestinal obstruction using octreotide.

Download CAT devant une ascite [Enregistrement automatique] pptx

Dveant role of somatostatin and octreotide in bowel obstruction: Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction. A comparison of lansoprazole, omeprazole and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery. Ils sont rares lors de traitements courts [ 87 Hardy J.

Corticosteroids and palliative care. Corticosteroids fort the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Elle est source d’un inconfort important et d’un certain nombre de complications. La technique perendoscopique est la plus simple et la plus accessible.

Percutaneous endoscopic gastrostomy Dsvant in palliative treatment of non-operable intestinal obstruction due to gynecologic cancer: Palliative treatment of upper intestinal obstruction by gynecological malignancy: Direct percutaneous endoscopic jejunostomies for enteral feeding.

Journal page Archives Sommaire. Access to the text HTML. Access to the PDF text Kne you experience reading problems with Firefox, please follow this procedure.

Desmoulins, Villejuif Cedex. Outline Masquer le plan. Top of the page – Article Outline. Peritoneal carcinomatosis in nongynecologic malignancy.

Peritoneal carcinomatosis from colorectal cancer. Ducreux M, Elias D. Management of peritoneal-surface malignancy: Evaluation ccat computed tomography in patients with peritoneal carcinomatosis. Sharma S, Walsh D. Jaundice, ascites, and hepatic encephalopathy.

  IEC 61032 PDF

Palliation of malignant ascites with a Tenckhoff catheter. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites.

Pleurx tunneled catheter in the management of malignant ascites.

Barnett TD, Rubins J. Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter.

Franco D, Foulquier S.

Place actuelle de la valve de Le Veen. Denis B, Ollier JC. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. Surgical management of intestinal obstruction in the late course of malignant disease. Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer.

Chan A, Woodruff RK. Intestinal obstruction in cancer patients. An assessment of risk factors and outcome. The results of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis. The management of inoperable gastrointestinal obstruction in terminal cancer patients. Bowel obstruction in home-care cancer patients: Non-operative management of malignant intestinal obstruction. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: Wind P, Roullet MH.

Intestinal obstruction in advanced ovarian cancer: Systematic review of the efficacy and safety of colorectal stents. Placement of self-expanding metal stents for acute malignant large-bowel obstruction: Philip J, Depczynski B.

Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Dehydration symptoms of palliative care cancer patients. Twycross R, Back I.